SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-077102
Filing Date
2021-03-11
Accepted
2021-03-11 08:05:59
Documents
3
Period of Report
2021-03-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d151181d8k.htm 8-K 18808
2 EX-99.1 d151181dex991.htm EX-99.1 60552
3 GRAPHIC g151181dsp4raptlogo.jpg GRAPHIC 4114
  Complete submission text file 0001193125-21-077102.txt   86384
Mailing Address 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 489-9000
RAPT Therapeutics, Inc. (Filer) CIK: 0001673772 (see all company filings)

IRS No.: 473313701 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38997 | Film No.: 21731902
SIC: 2834 Pharmaceutical Preparations